Arlington Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Arlington Trust's BMY Position: Q2 2026 in Review
Arlington Trust opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 610 shares worth $35.1K. The stake represents ﹤0.01% of the portfolio and ranks #310 among its holdings. This is a return to the name: Arlington Trust previously reported a position in BMY as recently as Q1 2025.
Arlington Trust first reported a position in BMY in Q4 2023 and has held it in 7 quarters since. The position peaked at $77.1K in Q2 2024. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Arlington Trust held 610 shares of Bristol-Myers Squibb worth $35.1K as of Q2 2026.
- Bristol-Myers Squibb was a new Arlington Trust position in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #310 holding.
- Arlington Trust first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 7 quarters since.
- Arlington Trust's Bristol-Myers Squibb position peaked at $77.1K in Q2 2024.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.